Benefit–Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness

BACKGROUND: Venous thromboembolism (VTE) often occurs after hospitalization in medically ill patients, but the population benefit–risk of extended thromboprophylaxis remains uncertain. METHODS AND RESULTS: The MARINER (Medically Ill Patient Assessment of Rivaroxaban Versus Placebo in Reducing Post‐D...

Descripción completa

Detalles Bibliográficos
Autores principales: Raskob, Gary E., Ageno, Walter, Albers, Gregory, Elliott, C. Gregory, Halperin, Jonathan, Maynard, Gregory, Steg, Philippe Gabriel, Weitz, Jeffrey I., Albanese, John, Yuan, Zhong, Levitan, Bennett, Lu, Wentao, Suh, Eun Young, Spiro, Theodore, Lipardi, Concetta, Barnathan, Elliot S., Spyropoulos, Alex C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673674/
https://www.ncbi.nlm.nih.gov/pubmed/36205248
http://dx.doi.org/10.1161/JAHA.122.026229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673674/
https://www.ncbi.nlm.nih.gov/pubmed/36205248
http://dx.doi.org/10.1161/JAHA.122.026229

Ejemplares similares